| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals, Inc. (SUPN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 4 sells. SUPN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 119.6K | $5.36M | - | |
| Dir | 61.3K | $2.75M | - | |
| Dir | 38.2K | $1.71M | - | |
| VP | 15.5K | $694.5K | - | |
| VP | 14.5K | $650.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2015 | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 3,631 | $16.39 | $59,520.81 | -23.3% | |
| Mar 30, 2015 | Bryan Jones W. | VP Of Business Development | Sale+OE | 6,712 | $12.02 | $80,646.69 | -9.0% | |
| Mar 24, 2015 | Bryan Jones W. | VP Of Business Development | Sale+OE | 1,900 | $12.00 | $22,800.00 | -2.7% |